GNRH1 and ovarian hyperstimulation syndrome: Dual trigger is available in two ways (5, 6): Concomitant use GnRH-a and low-dose hCG (1000-2500 IU) as trigger drugs 35-37 hours prior to OPU reduces the risk of OHSS in high responders (7).